Discover eureKARE

“Europe is at the forefront of microbiome and synthetic biology research and it is vital to find innovative new investment approaches to support the next wave of life science entrepreneurs. Through eureKARE’s pioneering approach, we are poised to identify, select and nurture the very best European science to create exciting new companies with the potential to disrupt and revolutionize the life sciences industry for the benefit of patients, while delivering shareholder value.”
Alexandre Mouradian, Founder & Chairman 
 

eureKAWARDS: the new pitch contest in synthetic biology

eureKAWARDS is a science-based pitch contest aimed at discovering and supporting ambitious synthetic biology projects from across Europe.

You are a researcher working on a fantastic synthetic biology project in your university lab, biohacking space or personal garage and looking to get a well-deserved head start?

eureKAWARDS is exactly what you need: a great opportunity to present your idea, concept or even your pre-startup plan in front of our panel of renowned scientific experts and business partners to compete for a full year of free access to eureKARE’s synthetic biology studio, eureKASYNBIO

A disruptive approach
led by an international team of experts

eureKARE is guided by its influential founders, Alan Howard, a renowned international fund manager, and think-tanker, Alexandre Mouradian, along with a pan-European team led by biotech expert Rodolphe Besserve and a prestigious international Scientific Advisory Board who supports the company in all its strategic and investment decisions.

Our common goal: think outside the box !

Creating a unique ecosystem
of ideation and cross-fertilization

eureKARE not only supports translational research by creating and financing new companies through its biotech start-up studios but also invests in European biotech companies at a later stage of development

A New Model in a New World
is

The development of a COVID-19 vaccine in record time has shown the power of human ingenuity and shall light our path. eureKARE contributes to finding smarter ways to identify and solving medical needs.

Building Centers of Excellence

Our Biotech Studio model offers scientists all the tools to convert their concepts into concrete projects, while benefiting from a unique environment of skills, knowledge, nurturing and insight.

A Proactive Corporate Approach

We want to involve industrial companies in our investment decisions as early as possible to understand real market needs and facilitate the next M&A trends.

The Best Risk/Reward Balance

We believe our dual investment approach of mixing early-stage and more mature biotechs brings value to our companies, investors and patients by forging an unprecedented thematic ecosystem.

Focus on two cutting-edge research fields

eureKABIOME Our Biotech Studio dedicated to the microbiome. We believe the microbiome is the key to unlocking the understanding and treatment of many diseases. Recent scientific advances and major funding rounds underline its huge potential.

eureKASYNBIO Our Biotech Studio dedicated to synthetic biology. Synthetic biology is entering a new era thanks to the emergence of disruptive technologies that will impact many fields including bioproduction, agriculture, data storage and human health.

 

 

News & Insights

JOIN THE eureKARE #INSIGHTNETWORK
Sign up to receive the latest news on eureKARE

    eureKARE SA 
    1A, Heienhaff 
    L-1736 Senningerberg
    Luxembourg